Cite
HARVARD Citation
Hill‐McManus, D. et al. (2019). Integration of Pharmacometrics and Pharmacoeconomics to Quantify the Value of Improved Forgiveness to Nonadherence: A Case Study of Novel Xanthine Oxidase Inhibitors for Gout. Clinical pharmacology & therapeutics. 106 (3), pp. 652-660. [Online].